Navigation Links
BioMarin Initiates Phase 3b Study to Evaluate the Effects of Kuvan on Neurophychiatric Symptoms in Subjects with PKU
Date:8/17/2010

jects twelve to 17 years of age and the Adult ADHD Self-Report Scale (ASRS) in subjects ages 18 and above.  The Clinical Global Impression of Improvement (CGI-I) scale will be assessed to determine improvement in global impression of behavior, symptoms and functioning relative to treatment as the primary efficacy endpoint for global function.

About BioMarinBioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio comprises four approved products and multiple clinical and pre-clinical product candidates. Approved products include Naglazyme® (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme® (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; Kuvan® (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany; and Firdapse™ (amifampridine phosphate), which has been approved by the European Commission for the treatment of Lambert Eaton Myasthenic Syndrome (LEMS). Other product candidates include GALNS (N-acetylgalactosamine 6-sulfatase), which is currently in clinical development for the treatment of MPS IVA and PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase), which is currently in Phase II clinical development for the treatment of PKU. For additional information, please visit www.BMRN.com. Information on BioMarin's website is not incorporated by reference into this press release.

Forward-Looking StatementThis press release contains forward-looking statements about the business prospects of BioMarin Pharmaceutical Inc., including, without limitation, statements about: the expectations about the timing, conduct and impact of the clinical trial
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
2. BioMarin Announces FDA Approval for Kuvan
3. BioMarin Initiates Phase 1 Clinical Study of PEG-PAL in PKU
4. BioMarin Announces Positive Results From Phase 2A Clinical Study of 6R-BH4 in Sickle Cell Disease
5. BioMarin Initiates Phase 1/2 Clinical Trial for GALNS for Morquio A Syndrome
6. BioMarin Initiates Phase 2 Clinical Study of PEG-PAL in PKU
7. BioMarin Acquires Huxley Pharmaceuticals, Inc.
8. BioMarin to Present at the Oppenheimer Healthcare Conference
9. BioMarin Announces Third Quarter 2009 Financial Results
10. BioMarin to Acquire LEAD Therapeutics
11. BioMarin to Present at the Credit Suisse Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... , May 1, 2015  AcelRx Pharmaceuticals, Inc. (Nasdaq: ... the development and commercialization of innovative therapies for the ... Timothy E. Morris , chief financial officer  will ... the events are as follows: Mizuho Third ... Location:  The Omni Berkshire Place, New York ...
(Date:4/30/2015)... , April 30, 2015 /PRNewswire/ - Pivotal ... pharmaceutical company with a focus on Omega-3 therapies ... its operational highlights and financial results for the ... amounts referenced herein are in Canadian dollars unless ... have been significant, with the right strategic partners ...
(Date:4/30/2015)... SUNNYVALE, Calif. , April 30, 2015 /PRNewswire/ ... that it has signed an agreement with MIM ... for the TomoTherapy ® and CyberKnife ® ... both Accuray and MIM technology. This is Accuray,s ... to the development of the first iPad-based treatment ...
Breaking Medicine Technology:AcelRx Pharmaceuticals to Participate at Upcoming Investor Conferences in May 2Pivotal Therapeutics Announces 2014 Financial Results 2Pivotal Therapeutics Announces 2014 Financial Results 3Pivotal Therapeutics Announces 2014 Financial Results 4Pivotal Therapeutics Announces 2014 Financial Results 5Pivotal Therapeutics Announces 2014 Financial Results 6Accuray Signs Agreement with MIM Software Inc. to Develop Adaptive Therapy Software 2Accuray Signs Agreement with MIM Software Inc. to Develop Adaptive Therapy Software 3
... The North Shore-LIJ Health System Department of Radiation Medicine announced ... the mouth) to participate in a Phase I clinical trial. , ... Subjects must be newly diagnosed and ... with the human papilloma virus (HPV-negative), or, if it is HPV-positive, they ...
... July 23 CRF Health garnered nine awards recently in the ... Health Awards, for their bold, new communications aimed at healthcare professionals involved ... the campaign, Langland, at the awards night in London . , ... Judged by some of the ...
Cached Medicine Technology:Study Seeks Volunteers to Measure Safety of Treatment 'Boost' for Patients with Oropharyngeal Cancer 2CRF Health is Awarded for Getting Closer 2CRF Health is Awarded for Getting Closer 3
(Date:5/3/2015)... (PRWEB) May 03, 2015 Women’s ... their Facebook page. , Their Facebook page ... many services the Practice has, it’s multiple locations, Providers ... Women’s Excellence has a very strong social media presence, ... and You Tube. , Women’s Excellence is the ...
(Date:5/3/2015)... Francisco, CA (PRWEB) May 03, 2015 ... (CFHI), announced it will be awarding the 2015 ... Jennifer Knight and Selemawit Ghebrendrias, are the deserving recipients ... champion for global service, Harris Llewellyn Wofford. The two ... service and passion for global health. , CFHI ...
(Date:5/3/2015)... (PRWEB) May 03, 2015 Indiana Fiber ... Provider announces Bank Computer Services, Inc (BCS) has selected ... BCS’ President states, “The technology, service, and working relationship ... like is the local feel you get with IFN. ... managed company; IFN makes local decisions and operates as ...
(Date:5/3/2015)... 03, 2015 Looking for a ... directly impact your career? The Master of International ... leaders in multinational companies and for professionals seeking ... changing global landscape, differences in culture, religion, government, ... EMIB program develops the global competence and confidence ...
(Date:5/3/2015)... MA (PRWEB) May 03, 2015 SpineFrontier, ... clearance from the FDA to produce and market their ... device can be used in outpatient settings and is ... The alternate posterior approach has been extensively researched and ... 510k approval to use this approach in conjunction with ...
Breaking Medicine News(10 mins):Health News:SF-based Global Health Non-Profit Awards Harris Wofford Global Service Fellowship 2Health News:SF-based Global Health Non-Profit Awards Harris Wofford Global Service Fellowship 3Health News:Bank Computer Services, Inc Selects Indiana Fiber Network, LLC as Fiber Transport Provider 2Health News:Bank Computer Services, Inc Selects Indiana Fiber Network, LLC as Fiber Transport Provider 3Health News:The Saint Louis University's Master of International Business Is Now Enrolling For Fall 2015 2
... CHICAGO, Oct. 11 Continuing its efforts ... SAVE THE PATIENT, a,not-for-profit patient-focused organization, is hosting ... Network. "Community Health Hotline" will,air Monday, October 15, ... Monday,s program will feature a frank discussion on ...
... simple tool that can improve the effectiveness of communication ... in dramatic improvements in health and safety. , The ... color images of the medication to be taken each ... a patient,s native language if the patient does not ...
... LOUIS, Oct. 11 KV Pharmaceutical Company,(NYSE: KVa/KVb) ... the Special Committee of the Board of Directors ... On October 11, 2007, KV,s Board of ... submitted findings on the internal,investigation of the Company,s ...
... Society volunteers break, national campaign record for free ... Texas, Oct. 11 High temperatures and intense,sunshine ... Hot Air,Balloon Festival to the Women,s Dermatologic Society ... number of free skin,cancer screenings for this 13th ...
... tests are good front-line tests indicators of heart disease, but ... say. , Thirty percent of all women, for example, ... walk for several minutes at a slightly increasing incline with ... say. , So if you are female, I put you ...
... Oct. 11 Amylin Pharmaceuticals,Inc. (Nasdaq: AMLN ) ... quarter of 2007 on Wednesday, October 17, 2007 at ... and Chief Executive,Officer, will lead the call. On the ... the third quarter of 2007. The call will ...
Cached Medicine News:Health News:Patient Empowerment -- Medication Error 2Health News:Improving doctor-patient communication yields significant health benefits 2Health News:Improving doctor-patient communication yields significant health benefits 3Health News:Improving doctor-patient communication yields significant health benefits 4Health News:KV Pharmaceutical Company Reports Results of Special Independent Committee Review of Stock Option Grants 2Health News:KV Pharmaceutical Company Reports Results of Special Independent Committee Review of Stock Option Grants 3Health News:KV Pharmaceutical Company Reports Results of Special Independent Committee Review of Stock Option Grants 4Health News:KV Pharmaceutical Company Reports Results of Special Independent Committee Review of Stock Option Grants 5Health News:KV Pharmaceutical Company Reports Results of Special Independent Committee Review of Stock Option Grants 6Health News:Sun Safety Awareness Reaches New Heights at Plano Hot Air Balloon Festival 2Health News:Sun Safety Awareness Reaches New Heights at Plano Hot Air Balloon Festival 3Health News:Taking the stress out of choosing the right stress test 2Health News:Taking the stress out of choosing the right stress test 3Health News:Amylin Pharmaceuticals to Webcast Third Quarter Results 2
... Optima L-XP ultracentrifuge is designed ... the discovery process if research involves ... a sophisticated on-board computer, enhanced firmware, ... easy-to-use touch screen, Optima L-XP delivers ...
... The Dimension Xpand integrated chemistry ... compact footprint to the smaller laboratory. ... The Dimension Xpand integrated chemistry system ... tailored for the low-volume environment, in ...
The Express Plus clinical chemistry analyzer is a fully automated walk away system designed for maximum productivity, convenience and reliability....
... make the RD/Hitachi 902 the clinical ... laboratory. Compact, sample selective clinical chemistry ... tests on board (including 3 ISE) ... per hour respectively up to 300 ...
Medicine Products: